Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT00587418
Eligibility Criteria:
Inclusion criteria
1. Informed written consent
2. Ages 18+ at the time of entry into the study
3. Recipient of primary liver transplantation from a deceased or live donor
4. Stable with satisfactory allograft function
1. Total bilirubin \< 2.5 mg/dl and
2. Aminotransferase \< x 3 upper limit of normal (e.g., ALT\<120 IU/mL)
5. Serum creatinine \< 2.5 mg/dl without dialysis
6. Maintenance immunosuppression including tacrolimus or cyclosporine
7. Stable hemodynamic function
1. Systolic blood pressure \> 100 mmHg
2. Resting pulse rate \< 100
Exclusion criteria
1. Recipient of combined liver-kidney transplantation
2. Prior organ transplantation (i.e., exposure to calcineurin inhibitors)
3. Established primary renal disease with active urinary sediments
4. On-going renal replacement therapy
5. Pulmonary hypertension (e.g., portopulmonary hypertension)
6. Iodine allergy
7. Other systemic illness (e.g., infection) that require hospitalization care beyond 2 weeks after LTx
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00587418
Study Brief:
Protocol Section:
NCT00587418